Assay of urine 11-DH-TXB2 in patients with recurrent cerebral infarction

Huai-lian GUO,Min CHENG,Wen-xiong TANG,Li HUANG,Jun WU
DOI: https://doi.org/10.3969/j.issn.1002-266X.2008.01.009
2008-01-01
Abstract:Objective To investigate the change of urine 11-dehydro-thromboxane B2(11-DH-TXB2) in patients with recurrent cerebral infarction.Methods Urine samples were collected before and after aspirin intake(100 mg/day,7 days) in 26 patients with recurrent cerebral infarction(group A) and 30 patients with first-ever cerebral infarction(group B),while only one sample was collected in 28 non-stroke patients(group C).Urine 11-DH-TXB2 was measured with the method of EIA.Results The urine 11-DH-TXB2 levels in group A and group B on admission were significantly higher than that in group C(P<0.05).The urine 11-DH-TXB2 levels decreased significantly after the use of aspirin in group A and group B(P<0.01).The difference of the rates of aspirin resistance between group A and group B was not significant(P>0.05).Conclusions The urine 11-DH-TXB2 levels are increased in both recurrent and first-ever cerebral infarction patients.Aspirin can reduce the urine 11-DH-TXB2 levels significantly in infarction patients.
What problem does this paper attempt to address?